{"id":"echinaforce-chewable-tablets","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Allergic reactions (rare, in individuals with ragweed sensitivity)"},{"rate":null,"effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Echinacea purpurea is believed to enhance innate immune responses by activating macrophages, natural killer cells, and other immune components. The herb contains polysaccharides, alkamides, and phenolic compounds that may promote cytokine production and improve immune cell activity, potentially reducing the severity and duration of upper respiratory tract infections.","oneSentence":"Echinaforce contains Echinacea purpurea extract that stimulates immune function to help the body fight infections and reduce cold/flu symptoms.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:45:13.427Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention and treatment of common cold and influenza-like infections"},{"name":"Reduction of duration and severity of upper respiratory tract infection symptoms"}]},"trialDetails":[{"nctId":"NCT04999098","phase":"PHASE4","title":"Echinaforce COVID-19 Shedding Study","status":"TERMINATED","sponsor":"A. Vogel AG","startDate":"2021-11-15","conditions":"COVID-19 Respiratory Infection, SARS-CoV2 Infection","enrollment":40},{"nctId":"NCT05002179","phase":"PHASE4","title":"Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2020-11-20","conditions":"Respiratory Tract Infections, Common Cold","enrollment":122}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Echinacea","Echinaforce","Echinaforce Junior tablets"],"phase":"marketed","status":"active","brandName":"Echinaforce Chewable tablets","genericName":"Echinaforce Chewable tablets","companyName":"A. Vogel AG","companyId":"a-vogel-ag","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Echinaforce contains Echinacea purpurea extract that stimulates immune function to help the body fight infections and reduce cold/flu symptoms. Used for Prevention and treatment of common cold and influenza-like infections, Reduction of duration and severity of upper respiratory tract infection symptoms.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}